000045503 000__ 00959nam\a2200337\i\4500
000045503 001__ 45503
000045503 003__ SzGeWIPO
000045503 005__ 20240708150116.0
000045503 006__ m\\\\e\\\d\\\\\\\\
000045503 008__ 220331s2020\\\\sz\\\\\\\\\\\\000\0\rus\d
000045503 0247_ $$2doi$$a10.34667/tind.45503
000045503 035__ $$aWIPO/PUB/121/2020/02/RU/art0004
000045503 035__ $$a(OCoLC)1256456144
000045503 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000045503 041__ $$arus
000045503 1001_ $$aNurton, James
000045503 24510 $$aПерепрофилирование лекарственных препаратов и пандемия COVID-19 /
000045503 2460_ $$aPublished in : WIPO Magazine, Issue 2/2020 (June)
000045503 264_1 $$aGeneva, Switzerland :$$bWorld Intellectual Property Organization,$$c2020.
000045503 300__ $$a1 volume ;$$c[28] cm
000045503 336__ $$atext$$btxt$$2rdacontent
000045503 337__ $$aunmediated$$bn$$2rdamedia
000045503 338__ $$avolume$$bnc$$2rdacarrier
000045503 650_0 $$aDrug Repositioning
000045503 650_0 $$aCOVID-19
000045503 650_0 $$aPandemics
000045503 77318 $$wWIPO/PUB/121/2020/02/RU
000045503 85641 $$yWeb link$$uhttps://www.wipo.int/wipo_magazine/ru/2020/02/article_0004.html
000045503 85641 $$ySearch WIPO Magazine collection$$uhttps://tind.wipo.int/search?ln=en&cc=WIPO%20Magazine
000045503 901__ $$aWIPO/PUB/121/2020/02/art0004
000045503 904__ $$aJournal article
000045503 909CO $$ooai:tind.wipo.int:45503$$pWIPOPUB
000045503 980__ $$aWIPOPUB
000045503 980__ $$aWIPOMAG